140 related articles for article (PubMed ID: 25264196)
1. MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.
Huang Q; Jiang Z; Meng T; Yin H; Wang J; Wan W; Cheng M; Yan W; Liu T; Song D; Chen H; Wu Z; Xu W; Li Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):160-5. PubMed ID: 25264196
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-223 and miR-19a induces differentiation and promotes recruitment of osteoclast cells in giant-cell tumor of the bone via the Runx2/TWIST-RANK/RANKL pathway.
Jiang ZY; Jiang JJ; Ma YS; Li HY; Shi W; Fu PL; Xu CF; Lu JZ; Fu D; Xu JG
Biochem Biophys Res Commun; 2018 Nov; 505(4):1003-1009. PubMed ID: 30309658
[TBL] [Abstract][Full Text] [Related]
3. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.
Wang T; Yin H; Wang J; Li Z; Wei H; Liu Z; Wu Z; Yan W; Liu T; Song D; Yang X; Huang Q; Zhou W; Xiao J
Oncotarget; 2015 Aug; 6(22):18980-96. PubMed ID: 26053181
[TBL] [Abstract][Full Text] [Related]
5. The overexpression of miR-30a affects cell proliferation of chondrosarcoma via targeting Runx2.
Jiang D; Zheng X; Shan W; Shan Y
Tumour Biol; 2016 May; 37(5):5933-40. PubMed ID: 26596830
[TBL] [Abstract][Full Text] [Related]
6. MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP.
Zhou W; Yin H; Wang T; Liu T; Li Z; Yan W; Song D; Chen H; Chen J; Xu W; Yang X; Wu Z; Xiao J
Bone; 2014 Sep; 66():267-76. PubMed ID: 24973691
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone.
Sang S; Zhang Z; Qin S; Li C; Dong Y
Biomed Res Int; 2017; 2017():3173547. PubMed ID: 28589137
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
[TBL] [Abstract][Full Text] [Related]
9. The role of TWIST as a regulator in giant cell tumor of bone.
Singh S; Mak IW; Cowan RW; Turcotte R; Singh G; Ghert M
J Cell Biochem; 2011 Sep; 112(9):2287-95. PubMed ID: 21503964
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
Jin Y; Zhang J; Zhu H; Fan G; Zhou G
Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
[TBL] [Abstract][Full Text] [Related]
11. Imatinib promotes apoptosis of giant cell tumor cells by targeting microRNA-30a-mediated runt-related transcription factor 2.
Liao Y; Lv G; Wang B; Kuang L; Wang X
Mol Med Rep; 2016 Feb; 13(2):1739-45. PubMed ID: 26708080
[TBL] [Abstract][Full Text] [Related]
12. Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.
Lou Z; Yang Y; Ren T; Tang S; Peng X; Lu Q; Sun Y; Guo W
Med Oncol; 2013; 30(3):606. PubMed ID: 23690270
[TBL] [Abstract][Full Text] [Related]
13. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TSIX promotes osteoblast apoptosis in particle-induced osteolysis by down-regulating miR-30a-5p.
Bu Y; Zheng D; Wang L; Liu J
Connect Tissue Res; 2018 Nov; 59(6):534-541. PubMed ID: 29260905
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30c suppressed giant-cell tumor of bone cell metastasis and growth via targeting HOXA1.
Ni LY; Zhao JD; Lu YH; Li W; Li BL; Wang XC; Meng QG
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4819-4827. PubMed ID: 29164581
[TBL] [Abstract][Full Text] [Related]
18. MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2.
Zhang R; Yan S; Wang J; Deng F; Guo Y; Li Y; Fan M; Song Q; Liu H; Weng Y; Shi Q
Tumour Biol; 2016 Mar; 37(3):3479-88. PubMed ID: 26449831
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
Huang L; Xu J; Wood DJ; Zheng MH
Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
[TBL] [Abstract][Full Text] [Related]
20. Characterization of MicroRNA Expression Profiles in Patients with Giant Cell Tumor.
Qin S; He NB; Yan HL; Dong Y
Orthop Surg; 2016 May; 8(2):212-9. PubMed ID: 27384730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
